Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

UFS appoints new council members
2004-06-07

 

The council of the University of the Free State (UFS) last week appointed two new council members. One of the members, Mrs Busiswa Tshabalala, will represent the Qwaqwa community. It is the first time since the incorporation of the Qwaqwa into the UFS campus last year that a council member was elected to represent the Qwaqwa community.

Mrs Tshabalala obtained her BA Hons in History from the University of the North’s Qwaqwa campus in 1992 and a B Ed degree in leadership management from the UFS in 1998. She was the first female deputy principal at the Harrismith Secondary School (1989-1992) and principal of the Forty Second Hill Teachers’ Centre in the Vrede area office of the Free State Department of Education. In 2001 she was seconded by the Free State Department of Education to coordinate programme 1 and 2 for Link Community Development. She is currently the director of the Thabo Mofutsanyana education district of the Free State Department of Education.

Dr Susan Vosloo, international acclaimed cardiologist, is the other new member of the council. Dr Vosloo, old Kovsie of the year 1989, obtained the MB Chb degree in 1980 at the UFS, an M Med cardiothoracic surgery and in 1998 the FCS (SA) qualification in cardiothoracic surgery at the College of Medicine of South Africa (CMSA). Dr Vosloo’s career extends over a wide spectrum and she specialises in pediatric and adult cardiothoracic surgery. In 1993 she took part in the first heart transplant in Johannesburg at Milpark Hospital, in 1997 she did the first hear-lung transplant at City Park Hospital in Cape Town and in 1997 a heart transplant on a 3-year old child.

She has a cardiothoracic surgery at the Christiaan Barnard Memorial Hospital in Cape Town since 1991 and in also part-time involved with the Red Cross Memorial Hospital in Cape Town.

“It is a great honour for the UFS to welcome two women with so much expertise and experience on the council. Their presence strengthens the UFS’s continued effort to transform the council,” said judge Faan Hancke, chairperson of the UFS council..

Both Mrs Tshabalala and Dr Vosloo’s appointments are until June 2008.

The following council members have been re-elected until June 2008:

Prof Dines Gihwala - vice-chairperson of the council
Dr Nathan Bagarette
Dr Frans Kotzé

Dr Kobus Laubscher was elected by the donors as representative for a further term until June 2008. Me Winifred Hoexter was elected by the Alumni as the third representative. She has been a foundation donor of the UFS since 1997 and committee member of the Kovsie Alumni Trust since 2000. Me Hoexter’s term is until June 2008. The other Alumni representatives are judge Faan Hancke and Mr Jan Grobler, whose term is until June 2006.


Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za

7 June 2004

 

 

Mrs Busiswa Tshabalala

Dr Susan Vosloo

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept